Can Masseter Botox Slim Your Jaw Without Causing Sagging?

Can masseter Botox make my jaw look slimmer?

Yes, masseter Botox can make the lower face look narrower when enlarged masseter muscles are the main source of width. It reduces muscle volume; it does not reshape the jawbone.

A review in the National Library of Medicine included 20 publications, mostly prospective studies, with follow-up ranging from 3 to 48 months. The review concluded that injections can reduce bigonial width by reducing masseter volume, and identifies hypertrophied masseters as the best fit.

Anatomy sets the limit. If width comes mainly from bone, reducing muscle bulk will not change that structure. If loose skin is already present, less muscle beneath it can leave the skin less supported. A careful assessment should separate these causes before treatment is discussed.

Results take time and fade. In a prospective study of 10 women with hypertrophic masseters, CT scans showed an average masseter volume reduction of about 30% at three months. Facial contour change was most apparent around that point and gradually returned by six months. The study also found bite force decreased after treatment, began recovering during week three, and was normal by three months.

Can masseter Botox cause jowls or facial sagging?

It can make existing skin laxity or jowls more noticeable when muscle volume is reduced. The concern is greater when the lower face already has sagging skin.

The review in the National Library of Medicine cautions that older patients with sagging jowls are poor candidates because reducing masseter muscle mass can worsen skin redundancy. This is not a claim that every treated person will develop sagging. It is a reason to weigh skin support and muscle bulk together, rather than judging candidacy from jaw width alone.

Ask the injector to explain what is creating the width in your face: muscle, bone, skin, or a mix. Ask what contour change is realistic and what features could become more apparent as muscle volume falls. Before-and-after photos of people with a similar age and skin type can help frame that discussion; the American Academy of Dermatology Association recommends reviewing comparable results.

There are functional tradeoffs, too. A randomized crossover trial published in Toxins found maximum bite force was significantly reduced through week 11 and recovered by week 25. The trial also recorded three reports of harm among 59 participants: smile asymmetry that resolved within eight weeks, migraine, or tinnitus and ear pain that resolved within two weeks. These findings describe study participants, not a prediction for any one person.

Does it help with teeth grinding or jaw clenching?

Masseter Botox can reduce some muscle activity and bruxism events for a time, but the evidence does not establish lasting relief or a single best injection plan.

In a double-blind, randomized, placebo-controlled crossover study published in BMJ Neurology Open, 35 people were randomized and data from 22 were analyzed. Bruxism events per hour were significantly lower four weeks after active treatment than after placebo, with a mean difference of −1.66 and p=0.003. The difference was not sustained at 12 weeks. Five participants reported mild, transient side effects.

The Toxins trial offers another part of the picture: electromyographic activity fell through week 18 and recovered by week 33, while bite force fell through week 11 and recovered by week 25. Less muscle activity can be the intended effect, but less bite force can also affect chewing. Discuss which symptom you want to address and how you will judge whether the tradeoff is acceptable.

These studies do not establish a universal dose or injection strategy. The BMJ study describes controlled evidence as limited, and the review calls for larger randomized trials to clarify optimal doses and frequency. Ask a qualified clinician about other approaches for clenching and grinding as well as the limits of toxin treatment.

Choosing a provider and weighing the decision

Provider selection is part of the treatment decision. The CDC advises checking that the provider has a valid healthcare license and is trained to give botulinum toxin injections. It also recommends asking whether the product came from an authorized source of FDA-approved toxin; approved products are prescription-only and should be given by qualified, licensed healthcare workers.

The American Academy of Dermatology Association recommends asking about board certification and experience with the exact procedure. It also advises asking whether treatment is right for you, what results are realistic, what risks apply, and how many treatments may be needed. Request before-and-after photographs, with attention to people whose age, skin type, or skin tone resembles yours.

Discuss your goal plainly: cosmetic narrowing, relief from clenching symptoms, or both. Ask how the clinician assessed muscle bulk and skin laxity, what functional changes to watch for, and what alternatives fit your concern. Also ask what symptoms require prompt medical attention. The CDC warns that toxin spread can cause drooping eyelids, difficulty swallowing, or trouble breathing.

A sound decision accounts for the face at rest and the jaw at work. Muscle reduction can change contour; the same change can affect support and bite force. The right plan depends on which of those outcomes matters most for your anatomy and symptoms.